07:00 , Oct 13, 2016 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: SRY-box 4 (SOX4); long non-coding RNA SRY box 4 (LNCSOX4)

Cancer INDICATION: Liver cancer Patient sample, cell culture and mouse studies suggest inhibiting SOX4 or LNCSOX4 could help treat hepatocellular carcinoma (HCC). In HCC patients, high LNCSOX4 or SOX4 expression in tumors correlated with tumorigenicity and poor...